AAA
BOLD

Affinity Asset Advisors’s Boundless Bio BOLD Stock Holding History

Affinity Asset Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
+250,000
New +$385K 0.03% 107

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Affinity Asset Advisors's BOLD Position: Q2 2026 in Review

Affinity Asset Advisors opened a new position in Boundless Bio (BOLD) in Q2 2026: 250,000 shares worth $625K. The stake represents 0.03% of the portfolio and ranks #107 among its holdings.

34 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Affinity Asset Advisors held 250,000 shares of Boundless Bio worth $625K as of Q2 2026.
  • Boundless Bio was a new Affinity Asset Advisors position in Q2 2026.
  • Boundless Bio made up 0.03% of Affinity Asset Advisors's portfolio in Q2 2026, its #107 holding.
  • 34 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.